Read about Bill Gates' dedication to helping find a treatment and cure for Alzheimer's Disease.
By scanning the brains of healthy volunteers, researchers at the National Institutes of Health saw the first, long-sought evidence that our brains may drain some waste out through lymphatic vessels, the body’s sewer system. The results further suggest the vessels could act as a pipeline between the brain and the immune system.
NIH announces centers for myalgic encephalomyelitis/chronic fatigue syndrome research. Read more about this announcement here.
Researchers led by Dr. Holtzman have identified that the presence of ApoE4 exacerbates the brain damage caused by toxic tangles of a different Alzheimer’s-associated protein: tau. In the absence of ApoE, tau tangles did very little harm to brain cells. Read more about these findings here.
A recent study led by ANA member, Sergio Baranzini, analyzed the microbiomes of 71 MS patients and 71 healthy people. Read more about this, and another similar study, here.
Scientists have tried to craft drugs that speed the elimination of the protein, α-synuclein, or prevent it from clumping. Neurologist and genomicist Clemens Scherzer of Harvard Medical School in Boston and colleagues decided to try a different strategy. “We wanted to find a drug that could turn down the production of α-synuclein,” he says.
ANA member, Rajesh Pahwa, has published new research on the treatment of Parkinson’s Disease. You can reach more about this research here.
Dena Dubal, the 2015 winner of the Grass Foundation - ANA Award in Neuroscience, recently published interesting new research. The findings of this study reveal how the longevity hormone klotho, boosts memory and protects against brain aging in mice. Read more about this research here.
According to a new study from Thailand, stopping cholesterol-lowering drugs soon after a stroke may increase the risk of a second stroke. Read more about this research here.
Researchers at Kent State University in Ohio have discovered tell-tale signs of Alzheimer’s disease in 20 elderly chimpanzee brains, rekindling a decades-old debate over whether humans are the only species that develop the debilitating condition.